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Adverse drug reactions (ADRs) are common and information about medicines increasingly 
widely available to the public. However relatively little work has explored how people use 
medicines information to help them assess symptoms which may be suspected ADRs.  
Objective  
To determine how patients use patient information leaflets (PILs) or other medicines 
information sources and whether information use differs depending on experiences of 
suspected ADRs. 
Method 
This was a cross-sectional survey conducted in six National Health Service (NHS) hospitals 
in North West England involving medical in-patients taking at least two regular medicines 
prior to admission. The survey was administered by a questionnaire and covered: use of the 
PIL and other medicines information sources, perceived knowledge about medicines 
risks/ADRs, experiences of suspected ADRs, plus demographic information. 
Results  
There were 1218 respondents to the survey of whom 18.8% never read the PIL, whilst 6.5% 
only do so if something unexpected happens. Educational level was related to perceived 
knowledge about medicines risks, but not to reading the PIL or seeking further information 
about medicines risks. Over half the respondents (56.0%) never sought more information 
about possible side effects of medicines.  
57.2% claimed they had experienced a suspected ADR. Of these 85.9% were either very sure 
or fairly sure this was a reaction to a medicine. Over half of those experiencing a suspected 
ADR (53.8%) had read the PIL, of whom 36.2% did so before the suspected ADR occurred, 
the remainder afterwards. Reading the PIL helped 84.8% of these respondents to decide they 
had experienced an ADR. Educational level, general knowledge of medicines risks and 




More patients should be encouraged to read the PIL supplied with medicines. The results 
support the view that most patients feel knowledgeable about medicines risks and suspected 
ADRs and value information about side effects, but that reading about side effects in PILs or 








Adverse reactions to medicines are common. Two large prospective studies in Liverpool 
hospitals have shown that 6.5% out of 18,820 admissions to medical units were caused by 
adverse drug reactions (ADRs), that 2.3% of patients admitted with ADRs die 
[1]
 and that 
14.7% of 3,695 medical or surgical in-patients experienced an ADR during their stay.
[2]
 In 
primary care, studies which have relied on patients’ reports of ADRs, either to postal 
questionnaires or telephone surveys suggest annual prevalence estimates of the order of 25-
29% in the 
USA[3,4]
 and 30% in the UK.
[5]
 Higher estimates were found in a Dutch study 
involving only anti-epileptic drugs.
[6]
 Furthermore a survey of the general public found that 




Members of the public in the UK can report suspected ADRs directly to the Medicines and 
Healthcare products Regulatory Agency (MHRA), through the Yellow Card Scheme (YCS). 
An evaluation of patient reporting to the YCS found that most reporters identified suspected 
ADRs through the timing of the event in relation to the medicine being used and/or written or 
verbal information about medicines.
[8,9]
 However no research has explored this in detail. For 
example, are people more likely to seek and use medicines information after experiencing an 
unusual event which they perceive as an ADR?  
 
Furthermore, relatively little is known about the experiences of UK patients who do not 
report their suspected ADRs to the MHRA. The majority of reporters have relatively high 
levels of education, are likely to have high levels of health literacy and are thus unlikely to be 
representative of the majority of patients who experience adverse reactions to medicines. 
Studies have shown that not all patients inform health professionals about symptoms they 
suspect to be ADRs.
[3,4]
 One potential reason for this may be that health professionals 





It is important to explore further and in a wider, more representative population how patients 
use information about medicines, such as the patient information leaflet (PIL) or information 
provided by health professionals, to help them assess symptoms they suspect are ADRs and 
their experiences of discussing their views with health professionals. We have identified no 
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research which has specifically explored the relationship between use of medicines 
information and experiences of suspected ADRs. 
 
Aim 
To determine how medical in-patients use patient information leaflets (PILs) or other 
information sources about ADRs and whether use of information differs depending on 
experiences of suspected ADRs. 
Methods 
Approval to conduct the study was obtained from NHS and University Research Ethics 
Committees and the relevant NHS Trusts.  
Questionnaire development 
A questionnaire was devised for the study which consisted mainly of closed-ended questions 
covering: use of the PIL for medicines prescribed in primary care, other medicines 
information sources, perceived knowledge about medicines risks or ADRs, experiences of 
ADRs and reporting of these, plus demographic information covering use of prescribed and 
purchased medicines. Open-ended questions were also used to elicit most recent suspected 
ADR, how this was identified and what happened following reporting of this to a health 
professional. In the questionnaire the term ‘side effect’ was used throughout, as this term has 
been used in previous work.
[8] 
The questionnaires were piloted by 11 undergraduate pharmacy students with fifty individual 
members of the general public known personally to them to assess face validity and ease of 
completion, resulting inminor amendments to the wording of several questions to ensure 
greater clarity. 
Setting 
The study was conducted in between two and four medical wards in each of six hospitals in 
North West England, including teaching and non-teaching establishments in urban and semi-
rural areas. Medical wards were selected because medical in-patients were likely to use 
medicines regularly and therefore had the potential to have experienced an ADR.  Prior to 
data collection, the study was explained to the nurses-in-charge of the selected medical wards 
in each hospital, together with an information sheet and all gave written consent for the study 




Potential participants were in-patients aged 18 or over, who were prescribed at least two 
medicines and taking at least two medicines prior to admission. Exclusion criteria were in-
patients with cognitive impairment or confusion and those unable to communicate in English.  
Recruitment 
The nurse-in-charge identified patients who were well enough, with adequate English and 
were suitable to take part, who were then approached by a student researcher. Patients who 
agreed to consider participating were given an information sheet and at least thirty minutes to 
reflect on their decision. Those who were still willing to take part then gave written consent, 
before being given the questionnaire and instructions on how to complete it. The student 
researchers subsequently collected the questionnaire but were also available to clarify any 
questions to ensure its accurate completion. Training was provided on how to approach 
potential participants and respond to any concerns or queries. 
Data analysis 
All responses were entered into SPSS Version 17.0 (IBM Corporation, USA) for analysis and 
a quality check performed. To enable quantitative analysis of responses to the open questions, 
previously developed categories were used for how respondents identified suspected ADRs,
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while categories for the remaining open questions were developed and agreed by the research 
team. Each response was categorised independently by the authors and cross-referenced. 
Independent associations between patient characteristics and experiences of suspected ADRs 
were assessed using chi-squared or Fisher’s exact tests. Binary logistic regression analysis 
was used to identify the key factors associated with experiencing an ADR. Where relevant 
missing data were excluded from analysis.  
Results 
In total 1218 questionnaires were completed sufficiently for analysis. Demographic 
characteristics of the respondents and their self-reported medicines use are shown in Table 1. 
Knowledge and use of information about suspected ADRs 
Fewer than half of all respondents (508; 41.9%) indicated that they usually read the PIL for 
all medicines, but a further 397 (32.8%) claimed to read it only for new medicines (Table 2). 
Of the remainder, 228 (18.8%) indicated they never read the PIL, whilst 79 (6.5%) only do so 
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if something unexpected happens. Sections of the PIL selected as being most often read by 
respondents were ‘possible side effects’ (428; 37.7%), ‘how to take the medicine’ (268; 
23.6%), ‘advice before taking’ (86; 7.6%), and ‘what the medicine is for’ (9; 0.5%). A further 
242 (21.3%) respondents stated they read all sections. 
The majority of patients (676; 56.0%) never tried to find out more about possible side effects 
of their medicines, but 138 (11.4%) claimed they did so for all their medicines. In addition, 
188 (15.6%) sought more information if the medicine was new and a further 205 (17.0%) 
only if something unexpected happened. There was no clear relationship between educational 
level and reading the PIL, as although 34.7% of those with lower educational qualifications 
claim never to read them, 26.7% of those completing further or higher education also made 
the same claim. The sources of additional information respondents indicated they used 
predominantly were health professionals (343; 50.7%) and the internet (193; 28.6%), with 
fewest using books, newspapers and magazines (33; 4.9%) and 57 (8.4%) preferring to ask 
friends or family members. Respondents were evenly divided between those who indicated 
they knew a great deal or a fair amount about the risks of medicines in general and those who 
knew not very much or nothing at all (Table 2). Over two-thirds of respondents felt they 
knew enough about the possible risks or side effects of the medicines they used. Educational 
level was significantly associated with perceived adequate knowledge about medicines risks 
in general (p<0.001), but not with possible risks or side effects about medicines used. 
Experiences and identification of suspected ADRs 
Over half (697; 57.2%) of all respondents claimed they had experience of a suspected ADR: 
395 (32.4%) one and 302 (24.8%) more than one. The most common effects described by the 
respondents were nausea and/or vomiting (160), dizziness or drowsiness (105) and 
psychiatric problems, including hallucinations and mood changes (64). Severe allergic 
reactions, including anaphylaxis were described by 28 and other serious reactions, including 
liver damage, by 11. 
The characteristics of respondents who had experienced a suspected ADR are shown in Table 
3 in comparison to those who did not recall experiencing this. Sex was not related to 
experiencing a suspected ADR, but increasing age, higher educational levels, higher numbers 
of regular medicines and increasing frequency of prescribed medicines use were all 
independently associated with experiencing a suspected ADR, while use of over-the-counter 
medicines was not. Logistic regression analysis suggested that higher educational levels, 
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higher number of regular medicines and more frequent prescription use all increased the 
likelihood of experiencing an ADR (Table 3) Having a university education resulted in an 
odds ratio for experiencing an ADR of 2.7 (95% confidence intervals 1.6 – 4.4), whereas 
using eight or more medicines gave an odds ratio of 2.4 (1.8 – 3.3) over using four or fewer. 
Frequency of reading the PIL was only weakly associated with the risk of experiencing a 
suspected ADR, whereas seeking further information and general knowledge about risks of 
medicines showed stronger associations (Table 2). Logistic regression analysis controlling for 
all other factors found that lower levels of general knowledge reduced the likelihood of 
having a suspect ADR, with knowing nothing at all reducing the odds ratio to 0.2 (0.1 – 0.3), 
compared to knowing a great deal. 
A substantial majority 599 (85.9%) of respondents who claimed to have experienced a 
suspected ADR were either very sure or fairly sure this was a reaction to a medicine. Of the 
697 experiencing a suspected ADR, 375 (53.8% of those responding) claimed they had read 
the PIL, 252 (36.2%) before the suspected ADR occurred and 123 (17.7%) after the 
experience. The remaining 322 respondents indicated they had not read the PIL at all, could 
not remember or did not respond. Of the 375 who did read the PIL, 318 (84.8%) indicated 
that it had helped them to decide they had experienced an ADR, although 18 of these 
indicated the effect was not listed. There were 41 (10.9%) further respondents who indicated 
that the PIL was not helpful because the suspected ADR was not listed, whilst 16 (4.1%) 
indicated they could not understand the leaflet. The majority of those who experienced a 
suspected ADR (489; 70.2%) did not explore any other information sources regarding the 
symptom they experienced. However 172 did do so, 151 (87.8%) of whom found this helped 
them to decide their experience was related to their medicine.  
Of the 697 respondents experiencing a suspected ADR, 562 provided an explanation of how 
they identified the problem as being related to a medicine. Similar proportions cited timing 
issues and being informed by a health professional (Table 4), with these factors accounting 
for over three-quarters of respondents (427; 76.0%). The proportion of respondents who cited 
the PIL as the method of identification was low (11.6%).  
Reporting suspected ADRs 
Among the 697 who had experienced a side effect, 395 (56.7%) claimed to have informed a 
doctor, nurse or pharmacist about a side effect once, and a further 155 (22.2%) more than 
once. The outcomes of this were that 157 patients had their medicine changed, 136 had a 
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medicine discontinued, 36 had the dose of their medicine changed and 11 had changes made 
to formulation, timing or method of administration. In a further 39 respondents a medicine 
was added to provide symptom relief and 12 were admitted to hospital as a result of the 
problem. Seventy-nine respondents provided information about their experiences of 
discussing suspected ADRs with health professionals. These were categorised into positive or 
negative comments; examples of these are shown in Table 5. 
Only 11 (0.9%) respondents in total had submitted a Yellow Card, five because a health 
professional suggested it and six who found out about the scheme themselves. There were a 
further 51 (4.2%) respondents who knew about the YC scheme but had not used it, whereas 







This survey found that while 74% of patients do usually read the PIL supplied with their 
medicines, the remainder do not or only do so if something unexpected happens, whereas 
over 40% seek information in addition to the PIL, mainly from health professionals or the 
internet. There were 57% of survey respondents who claimed to have experienced a 
suspected ADR, of whom 86% were sure of the causal association. The PIL was considered 
helpful by 85% of those who had used it in assisting identification of the suspected ADR, but 
only 11.6% of those experiencing a suspected ADR specifically cited the PIL as the method 
by which it was identified. Furthermore, only 36% of respondents who had experienced a 
suspected ADR had actually read the PIL before the event occurred. Factors strongly 
associated with having experienced a suspected ADR, were general knowledge about 
medicines risks, higher educational level and number of regular medicines used.  
Strengths and limitations 
The study involved only patients who were hospital in-patients on medical wards and had 
been taking prescribed medicines prior to and during admission, therefore were highly likely 
to have experienced a suspected ADR at some time. Participants were from six different 
hospitals covering a large geographical area and a wide range of medical services. Although 
surgical in-patients were excluded, there is no reason to suspect their experiences would 
differ from those of patients admitted to medical wards. The questions related to experiences 
of using medicines generally, incorporated many questions used successfully in previous 
surveys and was tested in a relevant population prior to use. Researchers ensured accurate 
completion of the questionnaire as far as possible, however a limited number of options were 
provided for closed questions. The questionnaire design incorporated questions about 
knowledge of medicines risks and use of information about medicines and side effects before 
questions about experiences of side effects, in an attempt to minimise bias resulting from 
recalling side effect experiences, however as most respondents completed the questionnaire 
without help, we cannot be assured that this was the case. The numbers of patients who were 
deemed by nursing staff to be unsuitable for inclusion or who refused to participate were not 
obtained, hence a response rate could not be calculated and there is also potential for self-




Comparison to the literature 
Given the patient population in this study it is not surprising that such a high proportion 
(57%) had experienced a suspected ADR at some time. The proportion is higher than was 
found in a street survey of the general public asked the same question.
[7]
 The finding that 
19% of patients claim never to read the PIL is in line with a prospective study which found 
that 29% had not read the PIL within seven days of receiving a prescription for a new 
medicine and 13% had never read the PIL for a regular medicine.
[13]
 Our results were also 
similar to this study in relation to the PIL sections most frequently read by patients, with the 
study by Raynor et al showing the side effects section being that which patients read in most 
detail. However a subsequent systematic review has shown that patients may not value the 
PIL and do not consider information written by medicine manufacturers as sufficiently 
independent.
[14] 
Awareness of medicines risks and experiences of side effects were related in our study, but a 
number of prospective studies have shown that informing patients about possible ADRs does 
not lead to their occurrence.
[15-17]
 Indeed national guidance on how best to inform patients 
about side effects has been developed.
[18]
 Most of the patients in our study had been informed 
about the possibility they had experienced an ADR by a health professional. This is in 
contrast to reporters of suspected ADRs using the YCS, who in the main identified the 
problem themselves through timing issues.
[9]
 Only 11.6% of respondents to our survey had 
used the PIL to identify the experience as a suspected ADR, which is similar to the 
proportion of YCS reporters (8.5%). Furthermore the finding that that only 36% of 
respondents to our survey claimed they had read the PIL before they experienced the 
suspected ADR lends further weight to the view that patients’ experiences of side effects are 
not due to awareness bias.  
Experiences of perceived side effects were however related to educational level. It is possible 
that patients with higher educational levels may be more willing to ask for information and 
discuss any new symptoms with health professionals or indeed to search for further 
information to inform such discussions. Our results did show that educational levels were 
also positively associated with perceived general knowledge about medicines risks, but not to 
reading the PIL or knowledge about actual medicines being used. Previous work has shown 
that educational level and whether respondents had experienced frequent adverse effects in 
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Given that 36% of our respondents cited a health professional as a method of identifying a 
suspected ADR, it is unsurprising that 57% of all those who had this experience claimed they 
had discussed their experience. Previous work has shown that in response to reporting of 
symptoms suspected by patients to be ADRs, the most common action of primary care 
physicians was to discontinue the offending medicine or to change therapy,
[4]
 as was found 
here. However other work has suggested that physicians may sometimes be dismissive 
[11,12]
  
and we also found a small number of patients who experienced this type of response. 
Conclusion 
These findings suggest that further support may be needed to encourage all patients to read 
the PIL supplied with medicines. The results add weight to other findings showing that most 
patients are knowledgeable about medicines risks and suspected ADRs, that they value 
information about medicines side effects and that reading about side effects in PILs or other 
medicines information sources does not lead to experiences of suspected ADRs. 
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Table 1 Respondents’ demographic characteristics and self-reported use of medicines  




Gender Female 625 (51.4)  2 
Age  18 – 40 118 (9.7)  
4 
41 – 64  400 (32.9)  
65 – 80 485 (40.0) 
Over 80 211 (17.4) 
Ethnicity White 1201 (99.0) 
6 
Asian 4 (0.3)  
Mixed 4 (0.3) 
Black 1 (0.1) 
Other  2 (0.2) 
Educational level Left school at 16 831 (68.5) 
4 
Left school at 17 or 18 122 (10.0) 
Further education 162 (13.3) 
University 99 (8.2) 
Number of regular 
medicines  
4 or fewer 500 (41.5) 
12 5 to 8 345 (28.6) 
More than 8 361 (29.9) 
Obtain prescription 
medicines  
At least monthly 851 (70.0) 
3 
Every 2 – 3 months 266 (21.9) 




counter medicines  
At least monthly 98 (8.1) 
6 
Every 2 – 3 months 114 (9.4) 









Table 2 Respondents’ behaviours regarding side effect information-seeking and perceived 
knowledge  






Total P value 
Use of PIL Always read 306 (44.2%) 202 (38.9%) 508 (41.9%) 0.007 
For new medicines  234 (33.8%) 163 (31.4%) 397 (32.8%) 
If event occurs 46 (6.5%) 33 (6.4%) 79 (6.5%) 





A great deal 72 (10.3%) 21 (4.0%) 93 (7.6%) <0.001 
A fair amount 323 (46.4%) 194 (37.2%) 517 (42.5%) 
Not very much 261 (38.5%) 224 (43.0%) 485 (39.9%) 
Nothing at all 40 (5.7%) 82 (15.7%) 122 (10.0%) 
Sufficient 
knowledge of 




467 (67.2%) 327 (63.0%) 794 (65.4%) 0.143 




For all medicines  94 (13.6%) 48 (9.2%) 142 (11.7%) <0.001 
For new medicines  130 (18.8%) 61 (11.8%) 191 (15.8%) 
If event occurs 104 (15.0%) 48 (9.2%) 152 (12.6%) 





For all medicines  94 (13.6%) 44 (8.5%) 138 (11.4%) <0.001 
For new medicines  123 (17.8%) 65 (12.6%) 188 (15.6%) 
If event occurs 141 (20.4%) 64 (12.4%) 205 (17.0%) 






Table 3 Respondent characteristics in relation to experiences of suspected ADRs 
 
Characteristic Had suspected ADR  
n=697 (% of total) 
No suspected ADR  




Odds Ratio  
(95% CI) 
Gender Female 359 (51.6%) 267 (51.2%) 0.908 n/a 
Age group 18 to 40 67 (9.6%) 51 (9.8%) 0.023 n/a 
41 to 64 237 (34.2%)   164 (31.2%)   
65 to 80 289 (41.6%) 196 (37.8%) 
Over 80 101 (14.5%) 110 (21.2%) 
Educational 
level 
Left school at 16 450 (64.7%) 381 (73.4%) <0.001 1.0 
Left school at 17 / 18 70 (10.1%) 52 (10.0%) 1.4 (0.9 – 2.0) 
Further education 103 (14.8%) 59 (11.4%) 1.7 (1.1 – 2.3)* 




4 or fewer 238 (34.4%) 262 (50.8%) <0.001 1.0 
5-8 203 (29.4%) 142 (27.5%) 1.5 (1.1 – 2.0)* 




At least monthly 516 (74.2%) 335 (64.4%) <0.001 1.0 
Every 1 to 3 months 143 (20.6%) 123 (23.7%) 0.8 (0.6 – 1.1) 
Less than every 3 
months 
36 (5.2%) 62 (12.0%) 0.4 (0.3 – 0.7)* 
 




Table 4 Factors used to identify suspected ADRs by respondents (n = 562) 
Factor Number citing (%) 
Timing issues Not present before starting medicine 29 (5.2) 
Noted soon after starting medicines 124 (22.1) 
Disappeared when medicine stopped 19 (3.4) 
Change noted when dose changed 6 (1.1) 
Re-appeared on re-challenge 4 (0.7) 
Started after medicine stopped 1 (0.2) 
General timing  52 (9.3) 
New medicine 18 (3.2) 
Information sources Informed by health professional 221 (39.3) 
Used patient information leaflet 65 (11.6) 
Information other 31 (5.5) 
Other reasons Previous experience with this/similar 
medicine 
6 (1.1) 
No other changes at the time 35 (6.2) 






Table 5 Respondents’ experiences of reporting suspected ADRs to health professionals 
Positive experiences Negative experiences 
Outcome Number 
reporting 





5 “Informed doctor, 
who prescribed 
alternative and 




7 “The doctor thought 
I was being stupid” 
Review of 
medicines  
4 “Told by doctor 
to give it a few 












9 “Chemist told me 




3 “Doctor said I 





7 “The doctor was 




26 “I informed the Dr 
about an itch with a 
statin. The Dr told 
me to carry on 
taking the statin as 
it was doing me 
more good to take it 
than to stop.”                                                                                                     
Monitor 
symptoms 
2 “I told the nurse 
who said they 
would monitor it” 
Informed 
it’s normal 
7 “Told side effects 
were common and 
hair would grow 
back” 
 
 
 
 
